Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Nasdaq - Delayed Quote USD

T. Rowe Price Health Sciences I (THISX)

80.06
-0.55
(-0.68%)
At close: March 28 at 8:02:15 PM EDT

Performance Overview

Morningstar Return Rating --
YTD Return 0.44%
5y Average Return 10.40%
Number of Years Up 7
Number of Years Down 1
Best 1Y Total Return (Mar 28, 2025) 30.27%
Worst 1Y Total Return (Mar 28, 2025) --
Best 3Y Total Return 30.27%
Worst 3Y Total Return -2.56%

Trailing Returns (%) Vs. Benchmarks

Monthly Total Returns
THISX
Category
YTD
4.29%
7.95%
1-Month
-1.82%
4.81%
3-Month
-3.65%
7.18%
1-Year
0.10%
30.16%
3-Year
3.39%
16.10%
5-Year
8.89%
15.71%
10-Year
8.13%
15.27%
Last Bull Market
7.52%
23.06%
Last Bear Market
-9.86%
-13.88%

Annual Total Return (%) History

Year
THISX
Category
2024
1.94%
--
2023
3.22%
--
2022
-12.08%
--
2021
13.40%
--
2020
30.27%
27.63%
2019
29.25%
26.23%
2018
1.35%
-0.40%
2017
28.09%
24.31%

2016
--
-10.60%

Past Quarterly Returns

YearQ1Q2Q3Q4
2024 7.98% 0.02% 5.94% -10.90%
2023 -2.27% 3.47% -5.41% 7.91%
2022 -8.56% -9.86% -2.02% 8.86%
2021 -0.25% 9.84% 1.35% 2.13%
2020 -13.39% 23.51% 6.88% 13.94%
2019 15.54% 1.77% -7.64% 19.01%
2018 1.38% 6.35% 11.60% -15.78%
2017 11.29% 7.47% 5.32% 1.68%
2016 4.25% 2.89% -4.77% --

Rank in Category (By Total Return)

YTD 52
1-Month 56
3-Month 61
1-Year 64
3-Year 48
5-Year 32

Load Adjusted Returns

1-Year 0.10%
3-Year 3.39%
5-Year 8.89%
10-Year 8.13%

Performance & Risk

YTD Return 0.44%
5y Average Return 10.40%
Rank in Category (ytd) 52
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.72
Morningstar Risk Rating

Fund Overview

Category Health
Fund Family T. Rowe Price
Net Assets 13.1B
YTD Return 4.29%
Yield 0.17%
Morningstar Rating
Inception Date Dec 29, 1995

Fund Summary

The fund normally invests at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies.

Related Tickers